EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

However, a newer lupus drug, anifrolumab (brand name Saphnelo), has shown promising results in reducing organ damage, ...

The revised estimates, based on software modeling, also show that only 1,300 Fijians are receiving antiretroviral therapy for ...

Boston's star defenseman remains in the hospital and won't play in the 4 Nations Face-Off final vs. Team Canada.

Dr. Howard Schumaker and Tina Schumaker to open Relevate Ketafusion clinic in La Crosse, offering IV ketamine therapy for ...

On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

Both the federal government and South Carolina carry out the lethal injections using a single drug, pentobarbital, a powerful sedative that some experts warn causes extreme pain and suffering when ...

The Bruins released an update on Charlie McAvoy Wednesday, noting that the defenseman remains hospitalized due to several ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a ...